★ WIDE MOAT STOCKS COMPARISON ★
VOL. XCIV, NO. 247
Stock Comparison
Johnson & Johnson vs Medtronic plc
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Johnson & Johnson
JNJ · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Johnson & Johnson's moat claims, evidence, and risks.
View JNJ analysisMedtronic plc
MDT · New York Stock Exchange
Partial score covering 76% of segment weight.
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Medtronic plc's moat claims, evidence, and risks.
View MDT analysisComparison highlights
- Segment focus: Johnson & Johnson has 2 segments (64.7% in Innovative Medicine); Medtronic plc has 4 segments (38.6% in Cardiovascular Portfolio).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: Johnson & Johnson has 3 moat types across 2 domains; Medtronic plc has 4 across 2.
Primary market context
Johnson & Johnson
Innovative Medicine
Branded prescription pharmaceuticals (biopharma)
Global
Wholesalers, hospitals, retailers, healthcare professionals, payers
Drug discovery, development, manufacturing, commercialization
64.7%
Medtronic plc
Cardiovascular Portfolio
Cardiovascular medical devices (cardiac rhythm management, electrophysiology/ablation, structural heart, coronary & peripheral vascular)
Global
Hospitals, cath labs, electrophysiologists, cardiologists, cardiac & vascular surgeons
Device OEM + procedure support + remote monitoring software/services
38.6%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Johnson & Johnson strengths
Medtronic plc strengths
Segment mix
Johnson & Johnson segments
Full profile >Innovative Medicine
Competitive
MedTech
Oligopoly
Medtronic plc segments
Full profile >Cardiovascular Portfolio
Oligopoly
Neuroscience Portfolio
Oligopoly
Medical Surgical Portfolio
Competitive
MiniMed / Diabetes (consolidated all other)
Oligopoly
Act on this comparison
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.